文献速递淋巴瘤

弥漫性大B细胞淋巴瘤中的强直性B细胞受体信号传导

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.
PubMed 文献 · Blood · 2017-06-23

研究利用CRISPR/Cas9基因组修饰技术,在弥漫性大B细胞淋巴瘤(DLBCL)细胞系中探究B细胞受体(BCR)信号传导。发现生发中心B细胞(GCB)亚型完全依赖强直性BCR信号,而活化B细胞(ABC)亚型则不同;强直性BCR信号主要通过激活AKT发挥作用,PTEN蛋白表达和BCR表面密度可能影响DLBCL中强直性BCR信号靶向治疗的临床反应。

要点

  • GCB亚型DLBCL细胞系完全依赖强直性BCR信号,对ibrutinib不敏感。
  • CD79A的ITAM中Y188F突变抑制GCB-DLBCL细胞系的强直性BCR信号。
  • BCR敲除对GCB-DLBCL细胞系增殖和大小的影响高度可变,而pan-AKT敲除 uniformly 有毒。

核心结论

  • 强直性BCR信号在GCB-DLBCL中主要通过激活AKT发挥作用,其重要性和 magnitude 高度可变,PTEN蛋白表达和BCR表面密度可能影响治疗反应。

研究设计与样本

  • 利用CRISPR/Cas9介导的基因组修饰技术,在DLBCL细胞系中研究BCR信号传导。

主要发现

  • 替换抗原结合BCR区域对GCB-DLBCL细胞系的BCR信号无影响,反映该亚型完全使用强直性BCR信号。
  • CD79A的ITAM中Y188F突变抑制GCB-DLBCL细胞系的强直性BCR信号,但不影响BCR交联后的钙流或未修饰ABC-DLBCL细胞系的增殖。
  • CD79A-GFP融合显示ABC和GCB亚型细胞系中BCR分别呈簇状或弥漫分布。
  • 强直性BCR信号主要激活AKT,强制激活AKT可挽救BCR或SYK、CD19敲除的GCB-DLBCL细胞系。
  • BCR敲除对GCB-DLBCL细胞系增殖和大小的影响高度可变,而pan-AKT敲除 uniformly 有毒。

临床怎么用

  • PTEN蛋白表达和BCR表面密度可能影响DLBCL中强直性BCR信号靶向治疗的临床反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We used clustered regularly interspaced short palindromic repeats/Cas9-mediated genomic modification to investigate B-cell receptor (BCR) signaling in cell lines of diffuse large B-cell lymphoma (DLBCL). Three manipulations that altered BCR genes without affecting surface BCR levels showed that BCR signaling differs between the germinal center B-cell (GCB) subtype, which is insensitive to Bruton tyrosine kinase inhibition by ibrutinib, and the activated B-cell (ABC) subtype. Replacing antigen-binding BCR regions had no effect on BCR signaling in GCB-DLBCL lines, reflecting this subtype's exclusive use of tonic BCR signaling. Conversely, Y188F mutation in the immunoreceptor tyrosine-based activation motif of CD79A inhibited tonic BCR signaling in GCB-DLBCL lines but did not affect their calcium flux after BCR cross-linking or the proliferation of otherwise-unmodified ABC-DLBCL lines. CD79A-GFP fusion showed BCR clustering or diffuse distribution, respectively, in lines of ABC and GCB subtypes. Tonic BCR signaling acts principally to activate AKT, and forced activation of AKT rescued GCB-DLBCL lines from knockout (KO) of the BCR or 2 mediators of tonic BCR signaling, SYK and CD19. The magnitude and importance of tonic BCR signaling to proliferation and size of GCB-DLBCL lines, shown by the effect of BCR KO, was highly variable; in contrast, pan-AKT KO was uniformly toxic. This discrepancy was explained by finding that BCR KO-induced changes in AKT activity (measured by gene expression, CXCR4 level, and a fluorescent reporter) correlated with changes in proliferation and with baseline BCR surface density. PTEN protein expression and BCR surface density may influence clinical response to therapeutic inhibition of tonic BCR signaling in DLBCL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Havranek O, Xu J, Köhrer S, et al. Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 2017. PMID: 28646116. doi:10.1182/blood-2016-10-747303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。